260 related articles for article (PubMed ID: 30685215)
1. Transforming growth factor-β1-overexpressing mesenchymal stromal cells induced local tolerance in rat renal ischemia/reperfusion injury.
Cai J; Jiao X; Zhao S; Liang Y; Ning Y; Shi Y; Fang Y; Ding X; Yu X
Cytotherapy; 2019 May; 21(5):535-545. PubMed ID: 30685215
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-β-Expressing Mesenchymal Stem Cells Induce Local Tolerance in a Rat Liver Transplantation Model of Acute Rejection.
Tang J; Yang R; Lv L; Yao A; Pu L; Yin A; Li X; Yu Y; Nyberg SL; Wang X
Stem Cells; 2016 Nov; 34(11):2681-2692. PubMed ID: 27333806
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-β1 promotes homing of bone marrow mesenchymal stem cells in renal ischemia-reperfusion injury.
Si X; Liu X; Li J; Wu X
Int J Clin Exp Pathol; 2015; 8(10):12368-78. PubMed ID: 26722423
[TBL] [Abstract][Full Text] [Related]
4. Exosomes derived from TGF-β1-pretreated mesenchymal stem cells alleviate biliary ischemia-reperfusion injury through Jagged1/Notch1/SOX9 pathway.
Yasen A; Feng J; Xie XM; Li K; Cai YH; Liao ZH; Liang RB; Dai TX; Wang GY
Int Immunopharmacol; 2023 Jun; 119():110253. PubMed ID: 37156030
[TBL] [Abstract][Full Text] [Related]
5. Bone mesenchymal stem cells ameliorate ischemia/reperfusion-induced damage in renal epithelial cells via microRNA-223.
Yuan X; Wang X; Chen C; Zhou J; Han M
Stem Cell Res Ther; 2017 Jun; 8(1):146. PubMed ID: 28619106
[TBL] [Abstract][Full Text] [Related]
6. Human Wharton's jelly-derived mesenchymal stromal cells reduce renal fibrosis through induction of native and foreign hepatocyte growth factor synthesis in injured tubular epithelial cells.
Du T; Zou X; Cheng J; Wu S; Zhong L; Ju G; Zhu J; Liu G; Zhu Y; Xia S
Stem Cell Res Ther; 2013 Jun; 4(3):59. PubMed ID: 23734757
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats.
Ishiuchi N; Nakashima A; Doi S; Yoshida K; Maeda S; Kanai R; Yamada Y; Ike T; Doi T; Kato Y; Masaki T
Stem Cell Res Ther; 2020 Mar; 11(1):130. PubMed ID: 32197638
[TBL] [Abstract][Full Text] [Related]
8. Protective Effects of Transforming Growth Factor-β1 Knockdown in Human Umbilical Cord Mesenchymal Stem Cells against Subarachnoid Hemorrhage in a Rat Model.
Chen H; Chen L; Xie D; Niu J
Cerebrovasc Dis; 2020; 49(1):79-87. PubMed ID: 31940632
[TBL] [Abstract][Full Text] [Related]
9. Human mesenchymal stromal cells ameliorate complement induced inflammatory cascade and improve renal functions in a rat model of ischemia-reperfusion induced acute kidney injury.
Zilberman-Itskovich S; Abu-Hamad R; Zarura R; Sova M; Hachmo Y; Stark M; Neuman S; Slavin S; Efrati S
PLoS One; 2019; 14(9):e0222354. PubMed ID: 31513644
[TBL] [Abstract][Full Text] [Related]
10. TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo.
Lynch K; Treacy O; Chen X; Murphy N; Lohan P; Islam MN; Donohoe E; Griffin MD; Watson L; McLoughlin S; O'Malley G; Ryan AE; Ritter T
Mol Ther; 2020 Sep; 28(9):2023-2043. PubMed ID: 32531237
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-β1 in the microenvironment of ischemia reperfusion-injured kidney enhances the chemotaxis of mesenchymal stem cells to stromal cell-derived factor-1 through upregulation of surface chemokine (C-X-C motif) receptor 4.
Si XY; Li JJ; Yao T; Wu XY
Mol Med Rep; 2014 May; 9(5):1794-8. PubMed ID: 24573381
[TBL] [Abstract][Full Text] [Related]
12. Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats.
Alfarano C; Roubeix C; Chaaya R; Ceccaldi C; Calise D; Mias C; Cussac D; Bascands JL; Parini A
Cell Transplant; 2012; 21(9):2009-19. PubMed ID: 22525800
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy of human umbilical cord mesenchymal stem cells transplantation against renal ischemia/reperfusion injury in rats.
Fahmy SR; Soliman AM; El Ansary M; Elhamid SA; Mohsen H
Tissue Cell; 2017 Jun; 49(3):369-375. PubMed ID: 28476205
[TBL] [Abstract][Full Text] [Related]
14. Human umbilical cord-derived mesenchymal stromal cells protect against premature renal senescence resulting from oxidative stress in rats with acute kidney injury.
Rodrigues CE; Capcha JM; de Bragança AC; Sanches TR; Gouveia PQ; de Oliveira PA; Malheiros DM; Volpini RA; Santinho MA; Santana BA; Calado RD; Noronha IL; Andrade L
Stem Cell Res Ther; 2017 Jan; 8(1):19. PubMed ID: 28129785
[TBL] [Abstract][Full Text] [Related]
15. Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation.
Chang JW; Tsai HL; Chen CW; Yang HW; Yang AH; Yang LY; Wang PS; Ng YY; Lin TL; Lee OK
J Cell Mol Med; 2012 Dec; 16(12):2935-49. PubMed ID: 22862802
[TBL] [Abstract][Full Text] [Related]
16. Enhanced alleviation of aGVHD by TGF-β1-modified mesenchymal stem cells in mice through shifting MΦ into M2 phenotype and promoting the differentiation of Treg cells.
Wu R; Liu C; Deng X; Chen L; Hao S; Ma L
J Cell Mol Med; 2020 Jan; 24(2):1684-1699. PubMed ID: 31782262
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth-beta 1 contributes to isoflurane postconditioning against cerebral ischemia-reperfusion injury by regulating the c-Jun N-terminal kinase signaling pathway.
Wang S; Yin J; Ge M; Dai Z; Li Y; Si J; Ma K; Li L; Yao S
Biomed Pharmacother; 2016 Mar; 78():280-290. PubMed ID: 26898453
[TBL] [Abstract][Full Text] [Related]
18. Comparison of human adipose stromal vascular fraction and adipose-derived mesenchymal stem cells for the attenuation of acute renal ischemia/reperfusion injury.
Zhou L; Song Q; Shen J; Xu L; Xu Z; Wu R; Ge Y; Zhu J; Wu J; Dou Q; Jia R
Sci Rep; 2017 Mar; 7():44058. PubMed ID: 28276451
[TBL] [Abstract][Full Text] [Related]
19. Hypoxic mesenchymal stem cells ameliorate acute kidney ischemia-reperfusion injury via enhancing renal tubular autophagy.
Tseng WC; Lee PY; Tsai MT; Chang FP; Chen NJ; Chien CT; Hung SC; Tarng DC
Stem Cell Res Ther; 2021 Jun; 12(1):367. PubMed ID: 34183058
[TBL] [Abstract][Full Text] [Related]
20. IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway.
Bai M; Zhang L; Fu B; Bai J; Zhang Y; Cai G; Bai X; Feng Z; Sun S; Chen X
Kidney Int; 2018 Apr; 93(4):814-825. PubMed ID: 29132705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
